Literature DB >> 2393670

Two types of haemolytic activity of detergents.

J Bielawski1.   

Abstract

The nonionic detergent Triton X-100 at concentrations of about 0.003 to 0.008% causes swelling followed by the haemolysis of erythrocytes suspended in 160 mM KCl. The rate of haemolysis increases with the increase in detergent concentration. Finally all the erythrocytes are haemolysed. The resistance of erythrocytes to this detergent decreases with an increase in temperature. The effect of Triton X-100 is explained by increased membrane permeability to KCl and colloid osmotic haemolysis. The anionic detergent, sodium dodecyl sulfate (SDS), at concentrations of about 0.003 to 0.001% causes the haemolysis of a certain number of erythrocytes. This number increases with an increase in detergent concentration. The resistance of erythrocytes to SDS increases with an increase in temperature. The effect of SDS is explained by direct disruption of membranes by the detergent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393670     DOI: 10.1016/0304-4165(90)90119-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Influence of the albumin concentration and temperature on the lysis of human erythrocytes by sodium dodecyl sulfate.

Authors:  L C Fonseca; L R Arvelos; R C M Netto; A B Lins; M S Garrote-Filho; N Penha-Silva
Journal:  J Bioenerg Biomembr       Date:  2010-09-21       Impact factor: 2.945

2.  Effect of non-lytic concentrations of Brij series detergents on the metabolism-independent ion permeability properties of human erythrocytes.

Authors:  A Miseta; P Bogner; A Szarka; M Kellermayer; C Galambos; D N Wheatley; I L Cameron
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

3.  Solanaceae glycoalkaloids: α-solanine and α-chaconine modify the cardioinhibitory activity of verapamil.

Authors:  Szymon Chowański; Magdalena Winkiel; Monika Szymczak-Cendlak; Paweł Marciniak; Dominika Mańczak; Karolina Walkowiak-Nowicka; Marta Spochacz; Sabino A Bufo; Laura Scrano; Zbigniew Adamski
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.